期刊
STEM CELL REPORTS
卷 13, 期 1, 页码 10-20出版社
CELL PRESS
DOI: 10.1016/j.stemcr.2019.05.013
关键词
-
资金
- SIRIC ONCOLille (INCa-DGOS-Inserm 6041)
- Ligue Contre le Cancer (comites du Nord et du Pas-de-Calais)
- Canceropole Nord-Ouest
- Region Hauts-de-France
- Fondation ARC pour la Recherche sur le Cancer
During normal mammary gland development, s-SHIP promoter expression marks a distinct type of mammary stem cells, at two different stages, puberty and early mid-pregnancy. To determine whether s-SHIP is a marker of mammary cancer stem cells (CSCs), we generated bitransgenic mice by crossing the C3(1)-SV40 T-antigen transgenic mouse model of breast cancer, and a transgenic mouse (11.5kb-GFP) expressing green fluorescent protein from the s-SHIP promoter. Here we show that in mammary tumors originating in these bitransgenic mice, s-SHIP promoter expression enriches a rare cell population with CSC activity as demonstrated by sphere-forming assays in vitro and limiting dilution transplantation in vivo. These s-SHIP-positive CSCs are characterized by lower expression of Delta-like non-canonical Notch ligand 1 (DLK1), a negative regulator of the Notch pathway. Inactivation of Dlk1 in s-SHIP-negative tumor cells increases their tumorigenic potential, suggesting a role for DLK1 in mammary cancer stemness.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据